# Proto Labs, Inc. (PRLB) · Edgar & Edgarette company card

> Proto Labs (PRLB) grew revenue 6.4% in FY2025 to $533 million, operating margin 4.7% against a 8.1% median for fabricated structural metal products, equity 88.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1443669 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PRLB) · [JSON](https://www.pops4.com/boards/company/PRLB.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $533M |
| Revenue growth, 1 year | 6.4% |
| Revenue growth per year | 2.2% |
| Operating margin | 4.7% (prior year 4.0%) |
| Net margin | 4.0% |
| Operating cash flow | $75M |
| Capital spending | $15M |
| Free cash flow | $60M |
| Cash | $111M |
| Long-term debt | — |
| Total assets | $763M |
| Total equity | $674M |
| Equity ÷ assets | 88.3% |
| Return on equity | 3.2% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 10.59 (safe zone)
- Piotroski F: 7 of 9 (solid)
- Beneish M: -2.74 (below the −1.78 line)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $533.1M (FY2025). Experience: revenue up 6.4% on the year, up 2.2% a year over 4 years; operating margin 4.7%, up from 4.0%. Soundness: equity 88.3% of assets, return on equity 3.2%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $483.1M and $619.0M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $453.7M to $660.7M. A statistical range, not company guidance. Against peers (38 filers, $50M+ revenue, its industry group): operating margin 4.7% against a 8.1% median; growth 6.4% against 2.4%.

Range logged 2026-10-30, receipt 0ea61bb9d112e11d, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-05-20 ([filing](https://www.sec.gov/Archives/edgar/data/1443669/000144366926000028/0001443669-26-000028-index.htm))

## Recent filings

- 10-Q · filed 2026-10-29 · [filing](https://www.sec.gov/Archives/edgar/data/1443669/000144366926000046/0001443669-26-000046-index.htm)
- 8-K · filed 2026-10-29 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1443669/000144366926000043/0001443669-26-000043-index.htm)
- 8-K · filed 2026-08-24 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1443669/000144366926000039/0001443669-26-000039-index.htm)
- 10-Q · filed 2026-07-31 · [filing](https://www.sec.gov/Archives/edgar/data/1443669/000144366926000035/0001443669-26-000035-index.htm)
- 8-K · filed 2026-07-31 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1443669/000144366926000034/0001443669-26-000034-index.htm)
- 8-K · filed 2026-05-20 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1443669/000144366926000028/0001443669-26-000028-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001443669.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1443669

## Cite

POPS4, Edgar & Edgarette: Proto Labs, Inc. (PRLB) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/PRLB. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.